Current Gene Therapy

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Current Gene Therapy  
DisciplineGene therapy
Edited byIgnacio Anegon, MD
Publication details
Publication history
Standard abbreviations
Curr. Gene Ther.
ISSN1566-5232 (print)
1875-5631 (web)
OCLC no.48623855

Current Gene Therapy is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Ignacio Anegon (INSERM UMR 1064, Nantes, France). The focus of this journal is pre-clinical or clinical research on gene therapy. Formats of publication include original research reports, review papers, and rapid communications ("letters").[1]

Abstracting and indexing[edit]

The journal is indexed in:[2][3]

According to the Journal Citation Reports, the journal has a 2012 impact factor of 5.318, ranking it 21st of 161 journals in the category "Genetics & Heredity".[4]


  1. ^ Publishers, Bentham Science. "BSP :: Current Gene Therapy". Archived from the original on 3 September 2011. Retrieved 4 August 2011.
  2. ^ "List of indexing services". Current Gene Therapy. Bentham Science Publishers. August 2011. Archived from the original on 2011-09-03. Retrieved 2011-08-04.
  3. ^ "Current Gene Therapy". CASSI. American Chemical Society. August 2011. Missing or empty |url= (help); |access-date= requires |url= (help)
  4. ^ "Journals Ranked by Impact: Genetics & Heredity". 2011 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2011. |access-date= requires |url= (help)

External links[edit]